Duration of Device-Based Fever Prevention after Cardiac Arrest
Christian Hassager(Copenhagen University Hospital), Jesper Kjærgaard(Copenhagen University Hospital), Rasmus Paulin Beske(Jisc), Søren Venø(Odense University Hospital), Y Abdi Isse(University of Copenhagen), Jordi S. Dahl(University of Southern Denmark), Jens Jakob Thune(University of Copenhagen), Johannes Grand(Jisc), Jakob Hartvig Thomsen(Jisc), Sebastian Wiberg(Jisc), Matias Greve Lindholm(Jisc), Martin Frydland(Jisc), Jakob Josiassen(Jisc), M Meyer(Jisc), Matilde Winther‐Jensen(Jisc), Henrik Schmidt(Odense University Hospital), Dan Eik Høfsten(Copenhagen University Hospital), Benjamin Nyholm(Jisc), Ditte Bekker‐Jensen(Odense University Hospital), Frederik T. Søndergaard(University of Copenhagen), Vibeke R. L. Jørgensen(University of Copenhagen), Daniel Kondziella(University of Copenhagen), Laust Emil Roelsgaard Obling(Copenhagen University Hospital), Jacob Eifer Møller(Copenhagen University Hospital), Søren Boesgaard(Copenhagen University Hospital), Emil Moser(Odense University Hospital), Britt Borregaard(University of Southern Denmark), Laura Sarkisian(Jisc), Simon Mølstrøm(Odense University Hospital)
Cited by 93
Related Papers
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
|New England Journal of Medicine|2016|1.7k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Left Atrial Volume
|Circulation|2003|688